The U.S. Food and Drug Administration recalled thousands of bottles of antidepressants due to the medicines containing high levels of a cancer-causing chemical. Now, the FDA is assigning the second-highest risk level to the recall of Duloxetine Delayed-Release Capsules produced by Towa Pharmaceutical Europe. The capsules were designated as a Class II recall, “a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.” Read more at the link in our bio. 📸: Getty Images #recall #antidepressantrecall #antidepressants #duloxetine #FDA #fdarecall